Detalhe da pesquisa
1.
ALDOB/KAT2A interactions epigenetically modulate TGF-ß expression and T cell functions in hepatocellular carcinogenesis.
Hepatology
; 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051951
2.
Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex.
PLoS Biol
; 18(12): e3000803, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275593
3.
Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis.
Hepatology
; 74(6): 3037-3055, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34292642
4.
Polyphenolic Proanthocyanidin-B2 suppresses proliferation of liver cancer cells and hepatocellular carcinogenesis through directly binding and inhibiting AKT activity.
Redox Biol
; 37: 101701, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32863234
5.
Yeast ß-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis.
Redox Biol
; 32: 101495, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171725
6.
Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways.
Nat Cancer
; 1(7): 735-747, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35122041